RecruitingNCT07392684

Optimisation of the Blood Culture Pathway Utilising Behaviour Change


Sponsor

Gloucestershire Hospitals NHS Foundation Trust

Enrollment

24 participants

Start Date

Oct 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Blood culture (BC) is the gold standard for the definitive diagnosis of bacteraemia, providing the opportunity to recover and identify the causative organism, and optimize subsequent antimicrobial treatment. Detection of bacteraemia is critical for the management of sepsis. This study aims to examine the performance of the blood culture pathway in Gloucestershire Hospitals Trust using data analysis, questionnaires and focus groups. . Information collected will be used to design interventions that could be used to optimise the blood culture pathway


Eligibility

Inclusion Criteria4

  • Secondary data:
  • \- adult blood culture sets received in the microbiology laboratory, between February 2023 and April 2024.
  • Staff member participants
  • \- Staff members that collect adult blood cultures within the Trust

Exclusion Criteria3

  • Secondary data:
  • paediatric blood culture samples
  • samples where volume, collection and/or time to incubation data are not recorded on laboratory system and/or blood culture analyser

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Gloucestershire Royal Hospital

Gloucester, Gloucestershire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07392684


Related Trials